Analyst Ratings for Horizon Pharma PLC (HZNP)

Updated: 2017-07-26

Analysts covering Horizon Pharma PLC (NASDAQ:HZNP) have given it a consensus rating of Buy. About 30 days ago, HZNP was issued an average rating of Buy.

11 analysts issued ratings on the stock, where 9 gave HZNP a buy rating, 0 issued an overweight rating, 2 gave a hold rating, 0 gave an underweight rating, and 0 gave a sell rating. Today, there are 0 more analysts optimistic about the company future as compared with 90 days ago. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

HZNP was given price targets by several analysts. The maximum price target given was 22, which equates to a potential upside of 66.41 percent. The lowest price target was 10, implying a possible loss of -24.36 percent. Many analysts are not unbiased in their coverage of stocks, including price targets and stock ratings, so care must be taken in interpreting numbers released by them.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. That number becomes -76.76 percent if we expand the time horizon to include the past 3 months instead of just one. On the other hand, earnings estimates for the fiscal year have been revised upwards by 0 percent, as compared to a month ago. If we look at the last 90 days instead, we find a net average change of -66.14 percent in FY estimates.

Another thing investors often look at is the level of agreement among analysts' revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, which can be compared to the 0 analysts that decreased their estimates. During this time, 0 analysts made positive revisions in their estimates for this fiscal year's earnings, while 0 analysts decreased their estimates.

HZNP has traded between a high of 23.44 and a low of 9.45 over the past year. Today's price is 39.89 percent above the 52-week low, and 43.6 percent lower than its 52-week high. HZNP has a price/earnings ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The HZNP value stock report compares HZNP to some of its peers using value stock charts. The market cap of HZNP is $2.19 billion. HZNP will post this quarters earnings in days, on 0000-00-00.